Maxim Group Downgrades Mast Therapeutics (MSTX) to Hold Following Vepoloxamer Phase 3 Miss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
| MAST THERAPEUTICS, Inc. (NASDAQ: MSTX) | Delayed: 14.70 +0.28 (1.94%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.42 | 52 Week High | $0.71 | |||
| Open | $14.43 | 52 Week Low | $0.07 | |||
| Day High | $14.83 | P/E | N/A | |||
| Day Low | $14.17 | EPS | $-0.35 | |||
| Volume | 3,629,758 | |||||
